The hemangiopericytoma (HPC) 
INTRODUCTION
Hemangiopericytoma (HPC) is an unusual perivascular tumor and first case was described by Stout and Murray in 1942 (1) . Moreover, it is classified as a soft-tissue vascular tumor originating from pericytes, which occurs commonly in the extremities, pelvis, head and neck, and meninges (2, 3) . On the other hand, HPC is rarely encountered in urogenital system (4) (5) (6) . Renal HPC is also extremely rare tumor and only 41 case reports have been previously documented (7) . Herein, we described a case of metastatic HPC localized to the right kidney and reviewed the literature.
CASE REPORT
A 56-year-old woman was referred to Department of Urology, with anorexia, fatigue, back pain, and abdominal bloating which started three months ago, in April 2008. She had history of total abdominal hysterectomy and bilateral salpingo-oophorectomy in 2001 due to uterine leiomyoma. She was not taking any medications. Her family history was non-contributory. Physical examination was normal except for right upper and middle quadrant tenderness. All laboratory tests including complete blood count, liver function tests, urea, creatinine, electrolyte levels were within normal range. Abdominal ultrasonography (USG) revealed a 14 cm solid mass in size localized in the middle-inferior region of the right kidney. Abdominopelvic CT scans showed a 15 cm diameter nodular solid lesion in the right kidney that extended to the hemidiaphragm and possible invasion to the right psoas muscle (Figure 1) . A thorax CT scan demonstrated multiple metastatic nodular lesions in the upper lobes of the both lungs, biggest of them measured as 19x17 mm in size (Figure 2 ). MRI finding of brain was normal. The right radical nephrectomy was performed due to renal tumor. The specimen was macroscopically measured 13x10x9 cm diameter and exceeded to capsule. Histopathologic examination of specimens revealed spindle tumoral cell infiltration arising from mesenchymal cells and they were separated by numerous capillaries and ( Figure 3A ). The immunohistochemical (IHC) stains of tumor cells were positive for vimentin and CD 34, and negative for Bcl-2, CD 10, CD 99, actin, desmin, and pancytokeratine. The mitotic activity was included four mitoses per 10 high-power fields (hpf) ( Figure 3B ). In addition, capsule and renal pelvis invasion were also detected in specimen. In the light of these pathological findings, the diagnosis of the right renal HPC was made. She tolerated the chemotherapy well, but progressive disease was detected with new liver metastasis and progression in lung metastasis after six cycles.
Because of the lack of standard treatment in renal HPC, she was treated with best supportive care during a follow-up of three months. She died due to progression of disease ten months later after the diagnosis. 
DISCUSSION
HPC is an uncommon soft-tissue vascular tumor that occurs due to the uncontrolled proliferation of pericytes, which are cells spiraling around capillaries (1, 2) . These cells were firstly described by Zimmerman in 1923 (2). However, the first case of HPC was reported by Stout and Murray in 1942 (1) . This neoplasm is very rare in the urogenital system and only 41 cases have been published in the world literature up to this time and two cases of bilateral renal HPC have been reported, previously (7) (8) (9) . The mean age of the renal HPC patients at the time of initial diagnosis is 40.3 years (range: 16-68 years). Furthermore, renal HPC patients are slightly younger than other patients with other types of renal cell carcinoma (RCC) (7) . There is no difference in the incidence according to gender (10, 11) . Our patient's age was 56 and compatible with literature. There are no specific signs or symptoms for renal HPC and in 66% of patients a painless mass is the most initial complaint. When 41 cases were analyzed, 19 of them had mass as initial symptom, and the others had pain. Pain in most cases was related to relatively larger masses (7, 11) . The features of renal HPC cases are summarized in Table 1 . Hematuria has been detected in six patients due to the tumor invasion into the pelvicaliceal system, whereas hypoglycemia and hypertension have been noted in 4 and 5 cases, respectively. The cause of hypoglycemia have been associated with the excessive metabolism of the glucose within the tumor (12) , however, hypertension is related to a result of renin production from tumors and generally regresses after surgery (13) . Our patient was initially presented with back pain and abdominal bloating compared with previous reported cases. We did not detect systemic symptoms, abdominal pain, and hematuria in our patient. However, pulmonary mass as a presenting sign has been noted in 2 cases in the literature. Our patient had also multiple pulmonary metastatic nodules, but she had no pulmonary symptoms related to metastasis. No specific findings of renal HPC have been found on USG, CT scan or MRI that might aid in the differential diagnosis with the other renal tumors (7). On the other hand, Yaghmai showed that these tumors might have a characteristic pattern in the early arterial phase of angiography, with displacement of the main arteries, presence of the large vessels encircling the tumor, and a welldemarcated tumor stain (14) . We also detected no specific signs except for renal mass on USG and CT scan. The most patients with renal HPC had well-circumscribed or thinly encapsulated tumors, but some are attached to the surrounding tissues. Usually, the size of the tumor is in the range of 1 to 25 cm (Table 1) , and in our case, size of the tumor was approximately 14 cm. The amount of intracellular connective tissue is very variable and the diagnosis may be achieved with only the combination of histologic and IHC patterns. These tests are used to exclude other tumors resembling HPC such as malignant fibrous histiocytoma, synovial sarcoma, renal angiosarcoma, and the sarcomatoid RCC (1, 3, 7) . Antibodies against CD 31, CD 34, CD 99, S100, vimentin, cytokeratins, and epithelial membrane antigen are usually used in IHC staining (7) . IHC staining of tumor cells revealed positive for vimentin and CD 34, and negative CD 99, pancytokeratine in our patient. The complete surgical excision was considered to be the cornerstone in first treatment of renal HPC and it was carried out in every reported case. Radical resection is recommended, because incomplete tumor resection associated with consequent higher frequency of relapse and progression (7) . Embolization before surgery has been previously reported in only 2 of renal HPC patients (15, 16) , and they were alive after surgery at 1 and 3 years follow-up. Chemotherapy (CT) and radiotherapy (RT) have been administered only in adjuvant setting after surgery. Seven patients have been treated with RT, but only one case was alive at 11 years, while the other six survived for a mean of 32 months (17, 18) . 2 out of these 7 patients treated with RT also received CT, but there was no benefit for survival. They died at 5 and 9 months, respectively (17, 19) . On the other hand, the benefit of CT has not been demonstrated in the other major series of HPC (3, 20) . The different schemes including actinomycin D, cyclophosphamide, vicristine, doxorubicine, chlorambucil, methotrexate were used, but produced no favorable results in terms of sustained objective response of metastatic diseases (20) . Our patient had metastatic renal HPC. After surgery, she was treated with the CT combination of ifosfamide, etoposide, cyclophosphamide, doxorubicin, vicristine because of soft-tissue vascular tumor. Stable disease was achieved with six cycles, but disease progression occurred after completion of CT. She died 10 months after disease diagnosis.
The prognosis of renal HPC is so poor and the histologic pattern is main prognostic factor. Enzinger and Smith suggested that more mitoses (more than 4 per 10 hpf) were associated with a 29% change of 10-years survival, versus 77% for fewer than 3 mitoses. The other prognostic factors were tumor size and occurrence of necrosis (3) . At the time the cases were reported, 12 of 19 patients for whom the follow-up was available were alive, while eight (together with our case) died. In addition, there was evidence of metastasis in 10 patients, but only one was alive (8) . The most common site of the metastases is the lungs (7).
In conclusion, renal HPC is an unusual tumor and the only accepted treatment is a wide surgical excision and the efficacy of neither chemotherapy nor radiotherapy has been indicated previously. Its prognosis associates with the size of tumor, age at diagnosis, histological patterns, and recurrence of the tumor. This report also constitutes the 42 nd case of renal HPC who had the lung metastases in the literature.
